… benefit of glucose-insulin-potassium (GIK) infusion in patients with ST-segment elevation …
in the CREATE-ECLA trial, GIK infusion had no effect on 30-day mortality in 20 201 patients. …

… -dose glucose-insulin-potassium (GIK) infusion in patients … (PCI) for acute ST-segment
elevation myocardial infarction … , GIK infusion failed to demonstrate a decrease in mortality in …

… the effects of GIK infusion on mortality. We therefore only can hypothesize that GIK may be
beneficial by inducing ST-segment … We could not detect a relation between infusion of GIK and …

… (GIK) was associated with a reduction in 1-year mortality in diabetics with acute … impact
of glucose—insulin—potassium on mortality and morbidity in over 20,000 patients with acute …

… Patients presenting within 48 hours after the onset of typical chest pain for at least 20 minutes
and with either ST-segment … patients with AMI demonstrated a 28% reduction in mortality …

… This infusion is a simple, … affect mortality due to AMI in all regions of ihe world, including
those of both lower and higher income. Glucose-insulin-potassium infusion may reduce mortality …

… Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that
has been postulated to improve mortality in patients with acute ST-segment elevation …

… h after the onset of symptoms and with an ST-segment elevation of more than 1 mm (0.1 mV…
Second, the mortality rate is low, due to the effect of our standard care for patients with acute …

… of the study of glucose-insulin-potassium (GIK) therapy in patients with ST-segment elevation
myocardial infarction (STEMI) … Effect of glucose-insulin-potassium infusion on mortality in …

… (GIK) infusion as an adjunctive treatment for ST segment elevation myocardial infarction (…
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment …